ÂÜÀòÂÒÂ×

Mark Schobel was appointed as Chief Innovation & Technology Officer of Aquestive in 2014 after serving as the Company’s Chief Executive Officer, Co-President and a member of its Board of Directors since November 2005. From March 2001 to November 2005, he was the Global Head of New Technology and Product Innovation for the Consumer Health Business Unit at Novartis where he pioneered thin film delivery of systemic drugs. Prior to Novartis, Mr. Schobel held various general management positions with Reed & Carnrick Pharmaceuticals, Warner-Lambert, and Pharmaceutical Formulations Inc.